Traditional group health plans weren't designed for modern clinical programs like GLP-1, HRT, and longevity medicine. See how JoeyMed stacks up.
Employers adding GLP-1 coverage without a clinical management strategy are seeing costs spiral out of control.
Worst financial year on record. GLP-1 drugs drove $300M in costs — 20% of total pharmacy spend, double the prior year.
GLP-1 spending quadrupled from 2023 to 2024, with costs doubling every 6 months. Budget projections became impossible.
Would require doubling insurance premiums to sustain GLP-1 coverage. Plan is now reconsidering its coverage policy.
Average healthcare costs rose $7,000 in the first year after GLP-1 initiation. No medical cost offsets were observed.
The alternative: managed carve-out programs like JoeyMed deliver 10–12% weight loss, manage 50% of patients without GLP-1s, and report 3:1 ROI.
Read the full research (PMC / NIH)Join the growing number of employers upgrading to clinically supervised health programs. No setup fees, launch in under 2 weeks.
